Regencell Bioscience Holdings Limited
NASDAQ:RGC
15.29 (USD) • At close July 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 2.961 | 1.565 | 6.417 | 0.059 | 0.387 | 0.243 |
| Short Term Investments
| 5 | 10 | 10 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 7.961 | 11.565 | 16.417 | 0.059 | 0.387 | 0.243 |
| Net Receivables
| 0.153 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | -0.057 | -0.028 | -0.007 | 0 | 0 |
| Other Current Assets
| 0 | 0.113 | 0.028 | 0.007 | 0 | 0 |
| Total Current Assets
| 8.114 | 11.621 | 16.445 | 0.067 | 0.387 | 0.243 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.227 | 0.892 | 1.46 | 0.082 | 0.108 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.098 | 0.108 | 0.114 | 0.191 | 0.019 | 0 |
| Total Non-Current Assets
| 0.324 | 1 | 1.574 | 0.273 | 0.127 | 0 |
| Total Assets
| 8.438 | 12.622 | 18.019 | 0.34 | 0.514 | 0.243 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt
| 0.06 | 0.438 | 0.411 | 3.682 | 3.07 | 2.082 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.134 | 0.169 | 0.167 | 0.656 | 0.095 | 0 |
| Total Current Liabilities
| 0.194 | 0.607 | 0.578 | 4.338 | 3.165 | 2.082 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.026 | 0.025 | 0.36 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0.026 | 0.025 | 0.36 | 0 | 0 | 0 |
| Total Liabilities
| 0.22 | 0.632 | 0.938 | 4.338 | 3.165 | 2.082 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -21.617 | -17.315 | -11.444 | -3.998 | -2.651 | -1.839 |
| Accumulated Other Comprehensive Income/Loss
| -0.046 | -0.087 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 29.881 | 29.432 | 28.509 | 0 | 0 | 0 |
| Total Shareholders Equity
| 8.219 | 12.03 | 17.065 | -3.998 | -2.651 | -1.839 |
| Total Equity
| 8.219 | 11.989 | 17.081 | -3.998 | -2.651 | -1.839 |
| Total Liabilities & Shareholders Equity
| 8.438 | 12.622 | 18.019 | 0.34 | 0.514 | 0.243 |